Showing results (1-10 of 90) with videos related to
Sort By:
Pageof 9
Human Vaccines|September 24, 2010
Development of Sanofi Pasteur tetravalent dengue vaccineBruno Guy, Melanie Saville, Jean LangVirologie (Montrouge, France)|September 24, 2022
[Tetravalent dengue vaccine development]Bruno Guy, Mélanie Saville, Jean LangAnnual Review of Medicine|October 31, 2015
Vaccination Against Dengue: Challenges and Current DevelopmentsBruno Guy, Jean Lang, Melanie Saville, et al.FEMS Immunology and Medical Microbiology|January 20, 2006
Comparison by flow cytometry of immune changes induced in human monocyte-derived dendritic cells upon infection with dengue 2 live-attenuated vaccine or 16681 parental strainViolette Sanchez, Catherine Hessler, Aymeric DeMonfort, et al.Vaccine|October 18, 2015
Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forwardBruno Guy, Olivier Briand, Jean Lang, et al.Vaccine|July 13, 2011
From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccineBruno Guy, Beatrice Barrere, Claire Malinowski, et al.Vaccine|October 8, 2009
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis virusesBruno Guy, Farshad Guirakhoo, Veronique Barban, et al.The Journal of Infectious Diseases|December 15, 2010
Different innate signatures induced in human monocyte-derived dendritic cells by wild-type dengue 3 virus, attenuated but reactogenic dengue 3 vaccine virus, or attenuated nonreactogenic dengue 1-4 vaccine virus strainsClaire Balas, Audrey Kennel, Florence Deauvieau, et al.The American Journal of Tropical Medicine and Hygiene|January 27, 2007
Innate immune responses in human dendritic cells upon infection by chimeric yellow-fever dengue vaccine serotypes 1-4Florence Deauvieau, Violette Sanchez, Claire Balas, et al.Vaccine|December 27, 2016
The role of the vaccines industry in Mission Grand ConvergenceJeffrey Almond, Donata MedagliniPageof 9